A triumph in xenotransplantation: Monkey survives over two years with genetically modified pig kidney
Alice Pebody explores the triumphs of xenotransplantation and discusses what this could mean for xenotransplantation in human therapeutics.
Therapeutics
Continue reading
Decoding dizziness: Brain cells responsible for motion sickness identified
Isabelle Goodall-Summers reports on recent insight into “motion sickness neurons”—neurons that could explain our travel sickness on journeys.
Hope for Alzheimer’s patients as Theory of Learning and Memory challenged
Leah Fogarty reports on new findings surrounding the inhibition of enzymes, in order to treat late-onset Alzheimer’s disease.
Transplanting microbiota into rats is sufficient to induce the symptoms of Alzheimer’s disease
Leah Fogarty reports on memory deficits observed in rats, similar to those found in Alzheimer’s disease, following microbiota modulation.
Medicine goes electronic—and geopolitical
Charles Jenner reports on the potential use of bioelectronic therapeutics in the treatment of heterogeneities in the autonomic nervous system.
Are chemogenetics really a miracle tool?
Leah Fogarty explores the use of chemogenetics in the treatment of neurological conditions, such as epilepsy, ADHD, and Parkinson’s disease.
Personalised Medicine
What happens when one size does not fit all? The first race-based combination prescription drug, Hydralazine-plus-nitrate is used in the treatment of congestive heart failure. Among African Americans, life expectancy of those with heart failure is increased using this combination drug, whereas white Americans respond less effectively to the drug. Another drug, Gefitinib, used in…